Itaconate Drives MtRNA-mediated Type I Interferon Production Through Inhibition of Succinate Dehydrogenase
Overview
Authors
Affiliations
Itaconate is one of the most highly upregulated metabolites in inflammatory macrophages and has been shown to have immunomodulatory properties. Here, we show that itaconate promotes type I interferon production through inhibition of succinate dehydrogenase (SDH). Using pharmacological and genetic approaches, we show that SDH inhibition by endogenous or exogenous itaconate leads to double-stranded mitochondrial RNA (mtRNA) release, which is dependent on the mitochondrial pore formed by VDAC1. In addition, the double-stranded RNA sensors MDA5 and RIG-I are required for IFNβ production in response to SDH inhibition by itaconate. Collectively, our data indicate that inhibition of SDH by itaconate links TCA cycle modulation to type I interferon production through mtRNA release.
Mitochondrially Transcribed dsRNA Mediates Manganese-induced Neuroinflammation.
Gokhale A, Mendez-Vazquez H, Sampson M, Moctezuma F, Harbuzariu A, Sing A bioRxiv. 2025; .
PMID: 40027638 PMC: 11870567. DOI: 10.1101/2025.02.16.638529.
The cell autonomous and non-autonomous roles of itaconate in immune response.
Chen C, Li X Cell Insight. 2025; 4(1):100224.
PMID: 39877254 PMC: 11773213. DOI: 10.1016/j.cellin.2024.100224.